| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/29/2012 | EP2421505A2 Hydrogels for combinatorial delivery of immune-modulating biomolecules |
| 02/29/2012 | EP2340850A9 Inhibition of factor B, the alternative complement pathway and methods related thereto |
| 02/29/2012 | EP2195021B1 A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi |
| 02/29/2012 | EP1916306B1 Recombinant vectors based on the modified vaccinia ankara (mva) virus as vaccines against leishmaniasis |
| 02/29/2012 | EP1871375B1 Carboline derivatives useful in the treatment of cancer |
| 02/29/2012 | EP1853308B1 Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter |
| 02/29/2012 | EP1796717B1 Combination vaccine |
| 02/29/2012 | EP1767639B1 Oral anti-leucocytozoonosis vaccines based on transgenic plants |
| 02/29/2012 | EP1670826B1 Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof |
| 02/29/2012 | EP1662007B9 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 02/29/2012 | EP1325133B1 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 02/29/2012 | EP1002091B1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 02/29/2012 | CN1972713B Pharmaceutical composition for treating or preventing cardiac dysfunction |
| 02/29/2012 | CN1884301B Targeted function superantigen and its preparation method and use |
| 02/29/2012 | CN1251131B Enhancement of growth in plant |
| 02/29/2012 | CN102365359A Salmonella enterica presenting c. jejuni n-glycan or derivatives thereof |
| 02/29/2012 | CN102365297A Novel anti-alpha5beta1 antibodies and uses thereof |
| 02/29/2012 | CN102365296A Methods for producing mixtures of antibodies |
| 02/29/2012 | CN102365097A Antibodies to clostridium difficile toxins |
| 02/29/2012 | CN102365096A Rapid antemortem detection of infectious agents |
| 02/29/2012 | CN102365095A Splitting gp41 |
| 02/29/2012 | CN102363770A Recombinant baculovirus capable of expressing porcine circovirus type 2 Cap protein and somatostatin in fusion manner, and subunit vaccine thereof |
| 02/29/2012 | CN102363769A Chicken Marek's disease Meq gene deleted vaccine strain, construction method thereof, and application thereof |
| 02/29/2012 | CN102363751A Dengue virus (DENV)-like particle as well as preparation method and application thereof |
| 02/29/2012 | CN102363043A Swine C-type foot-and-mouth disease genetic engineering vaccine adjuvant, and preparation method thereof |
| 02/29/2012 | CN102363042A C-shaped aftosa subunit vaccine and preparation method thereof |
| 02/29/2012 | CN102363041A Method for preparing preservative-free vaccine |
| 02/29/2012 | CN101979514B Virus and vaccine of porcine reproductive and respiratory syndrome and preparation method of same |
| 02/29/2012 | CN101880677B siRNA sequence against 2009 new influenza A virus polymerase gene and nucleoprotein gene and application thereof |
| 02/29/2012 | CN101670100B Tolerogenic tumor-cell antigen-loaded dendritic cell, preparation method and application thereof |
| 02/29/2012 | CN101570575B Sncg monoclonal antibody and application thereof |
| 02/29/2012 | CN101537176B Application of staphylococcus lysozyme compound in preparing medicament improving animal health condition |
| 02/29/2012 | CN101328211B Candidates outer membrane proteins of two leptospira vaccine |
| 02/29/2012 | CN101273995B Method for preparing magnetic particles modified by afi-tiazin dyes |
| 02/29/2012 | CN101171032B Use of native peptides and their optimized derivatives for vaccination |
| 02/29/2012 | CN101121754B Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes |
| 02/28/2012 | US8124789 Method for producing glycosylated indole compound and antibody against the compound |
| 02/28/2012 | US8124750 Recombinant protective protein from Streptococcus pneumoniae |
| 02/28/2012 | US8124738 Human monoclonal antibodies to CD70 |
| 02/28/2012 | US8124728 CA125 gene and its use for diagnostic and therapeutic interventions |
| 02/28/2012 | US8124723 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/28/2012 | US8124721 Peptides for modulating innate immunity |
| 02/28/2012 | US8124592 Development of a preventive vaccine for filovirus infection in primates |
| 02/28/2012 | US8124590 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/28/2012 | US8124407 Circular nucleic acid vectors, and methods for making and using the same |
| 02/28/2012 | US8124398 Recombinant flavivirus vaccines |
| 02/28/2012 | US8124397 Inactivating pathogens with oxidizing agents for vaccine production |
| 02/28/2012 | US8124380 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals |
| 02/28/2012 | US8124378 Murine zcytor17 ligand polynucleotides |
| 02/28/2012 | US8124348 Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes |
| 02/28/2012 | US8124339 Assays and methods using biomarkers |
| 02/28/2012 | US8124120 Preparing and using crosslinked, water insoluble, hydrated hyaluronic acid gel particles; in vivo biostability and mechanical properties, usability; ease of injection through fine needles |
| 02/28/2012 | US8124111 Immunomodulation by altering sphingosine 1-phosphate lyase (SPL) activity |
| 02/28/2012 | US8124110 Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species |
| 02/28/2012 | US8124109 Vault compositions for immunization against chlamydia genital infection |
| 02/28/2012 | US8124108 Polypeptides for inducing a protective immune response against Staphylococcus epidermidis |
| 02/28/2012 | US8124107 Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use |
| 02/28/2012 | US8124106 Virus purification methods |
| 02/28/2012 | US8124105 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 02/28/2012 | US8124104 Norovirus and sapovirus antigens |
| 02/28/2012 | US8124103 Influenza antigens, vaccine compositions, and related methods |
| 02/28/2012 | US8124102 Method for the reduction of viral loads in patients comprising the administration of nef-deficient human immunodeficiency virus (HIV) |
| 02/28/2012 | US8124101 Genetically engineered swine influenza virus and uses thereof |
| 02/28/2012 | US8124100 Inactivated nodavirus vaccine |
| 02/28/2012 | US8124099 Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells |
| 02/28/2012 | US8124098 Polypeptides from non-typeable Haemophilus influenzae |
| 02/28/2012 | US8124097 Antiinflammatory agents; binding proteins, encoding polynucleotides and vectors; having decay accelerating and cofactor activity |
| 02/28/2012 | US8124096 Immune response modifier compositions and methods |
| 02/28/2012 | US8124095 Fusion proteins for delivery of erythropoietin to the CNS |
| 02/28/2012 | US8124094 Immunoglobulin Fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same |
| 02/28/2012 | US8124093 Human cytomegalovirus neutralizing antibodies and use thereof |
| 02/28/2012 | US8124092 Antibodies against H5N1 strains of influenza A virus |
| 02/28/2012 | US8124091 Human monoclonal antibodies to influenza M2 protein and methods of making and using same |
| 02/28/2012 | US8124090 Anti-factor D antibodies and methods of treatment |
| 02/28/2012 | US8124089 useful in therapeutic treatment of autoimmune and inflammatory diseases, particularly diseases mediated by T follicular helper cells, B cells TH cells or TH17 cells |
| 02/28/2012 | US8124088 Methods of treatment using anti-IL-22RA antibodies |
| 02/28/2012 | US8124087 Methods of controlling bone loss by inhibiting DKK1 |
| 02/28/2012 | US8124086 Antibodies that bind cell-associated CA 125/O772P and methods of use thereof |
| 02/28/2012 | US8124085 Bispecific binding agents for modulating biological activity |
| 02/28/2012 | US8124084 Compositions and methods for immunomodulation in an organism using IL-15 and soluble IL-15Ra |
| 02/28/2012 | US8124083 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| 02/28/2012 | US8124082 Humanized anti-beta7 antagonists and uses therefor |
| 02/28/2012 | US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders |
| 02/28/2012 | US8124080 Human monoclonal antibody having fat-reducing effect |
| 02/28/2012 | US8124079 Anti-IGF-IR antibodies and uses thereof |
| 02/28/2012 | US8124078 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies |
| 02/28/2012 | US8124077 Anti-IL-TIF antibodies and methods of making |
| 02/28/2012 | US8124076 Single chain antibodies against β-amyloid peptide |
| 02/28/2012 | US8124069 Immunogenic peptides |
| 02/28/2012 | US8124068 Recombinant intracellular pathogen immunogenic compositions and methods of use |
| 02/28/2012 | US8124067 Method for immunotherapy of tumors |
| 02/28/2012 | US8124066 Methods of using interleukin-2 mutants with reduced toxicity |
| 02/28/2012 | US8124055 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to inhibit angiogenesis that accompanies tumor development |
| 02/28/2012 | CA2500215C Nucleic acid coated particles |
| 02/28/2012 | CA2434938C Compositions of glucan and a monoclonal antibody which exhibit an enhancement of the anti tumor activity of the antibody |
| 02/28/2012 | CA2285947C Vaginal lactobacillus medicant |
| 02/28/2012 | CA2219361C Human antibodies derived from immunized xenomice |
| 02/23/2012 | WO2012024659A2 Antibody-based constructs directed against tyrosine kinase receptors |
| 02/23/2012 | WO2012024632A2 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus m2e |
| 02/23/2012 | WO2012024629A1 Synthetic nanocarrier vaccines comprising proteins obtained or derived from human influenza a virus hemagglutinin |